Tectonic Therapeutic

Tectonic Therapeutic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs). The company was co-founded by Timothy A. Springer and Andrew C. Kruse of Harvard Medical School and is located in Watertown, Massachusetts, United States.